Ep. 172 Advancing Cancer Care: AUA 2024 Highlights in Prostate and Bladder Cancer with Dr. Jeff Tosoian and Dr. Woodson Smelser

In this episode of the BackTable Urology, Dr. Bogdana Schmidt (University of Utah), Dr. Woodson Smelser (Washington University in St. Louis), and Dr. Jeff Tosoian (Vanderbilt University) discusses the latest insights and advancements in prostate and bladder cancer treatment presented at AUA 2024. --- CHECK OUT OUR SPONSOR Veracyte https://www.veracyte.com/decipher --- SYNPOSIS First, the doctors cover noteworthy topics, including the effectiveness of early screening and treatment for high-risk prostate cancer patients, innovative approaches in imaging and biomarkers, and the impact of new guidelines on salvage therapy. They also explore emerging treatments for non-muscle invasive bladder cancer (NMIBC), as well as the evolving role of systemic immunotherapies and advanced genomic testing. To wrap up, the urologists offer detailed analyses and their expert opinions on how these developments could transform patient care in the field of urologic oncology. --- TIMESTAMPS 00:00 - Introductions 03:06 - Prostate Cancer Screening Insights 10:10 - Advancements in MRI and Biomarkers 18:22 - Transperineal vs. Transrectal Prostate Biopsy 27:18 - New Guidelines for Bladder Cancer Treatment 30:57 - Innovative Drug Delivery Systems 32:36 - Gene Therapy and Immunotherapy Advances 40:11 - Concluding Thoughts and Future Prospects --- RESOURCES Decipher Prostate Genomic Classifier by Veracyte: ​​https://decipherbio.com/decipher-prostate/physicians/decipher-prostate-overview/

There are no comments yet.

Please log in to write the first comment.